S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BIOLASEAmerican Medical TechnologiesLancer OrthodonticsRemedent
SymbolNASDAQ:BIOLOTCMKTSMKTS:ADLIOTCMKTSMKTS:LANZOTCMKTS:REMI
Price Information
Current Price$0.91N/AN/A$0.21
52 Week RangeBuyN/AN/AN/A
MarketRank™
Overall Score1.30.00.00.6
Analysis Score3.50.00.00.0
Community Score2.50.00.02.3
Dividend Score0.00.00.00.0
Ownership Score0.00.00.00.0
Earnings & Valuation Score0.60.00.00.6
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/A
Consensus Price Target$2.00N/AN/AN/A
% Upside from Price Target120.46% upsideN/AN/AN/A
Trade Information
Market Cap$132.44 millionN/AN/AN/A
Beta1.98-0.580.06-0.45
Average Volume45,481,66421,0791502,836
Sales & Book Value
Annual Revenue$37.80 millionN/AN/A$1.06 million
Price / Sales3.50N/AN/AN/A
CashflowN/AN/AN/A$0.13 per share
Price / CashN/AN/AN/A1.58
Book Value$0.01 per shareN/AN/A$0.27 per share
Price / Book90.72N/AN/AN/A
Profitability
Net Income$-17,850,000.00N/AN/A$-860,000.00
EPS($0.77)N/AN/AN/A
Trailing P/E RatioN/A0.000.000.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/A
Net Margins-58.34%N/AN/A-47.73%
Return on Equity (ROE)-541.14%N/AN/A-10.64%
Return on Assets (ROA)-45.22%N/AN/A-6.60%
Dividend
Annual PayoutN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.23%N/AN/AN/A
Current Ratio1.68%N/AN/A0.26%
Quick Ratio1.09%N/AN/A0.22%
Ownership Information
Institutional Ownership Percentage5.52%N/AN/AN/A
Insider Ownership Percentage2.19%18.10%24.30%N/A
Miscellaneous
Employees157121342
Shares Outstanding145.98 millionN/AN/AN/A
Next Earnings Date3/25/2021 (Estimated)N/AN/A3/5/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.